Atrys Health (XMAD:ATRY) Total Current Assets: €234.0 Mil (As of Dec. 2025)

What is Atrys Health Total Current Assets?

Atrys Health XMAD:ATRY +0.19% 68 Total Current Assets is €234.0 Mil as of Dec. 2025. GuruFocus rates XMAD:ATRY with a GF Score™ of 68/100 and a GF Value™ of €3.11 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Atrys Health's total current assets for the quarter that ended in Dec. 2025 was €234.0 Mil.

Atrys Health (XMAD:ATRY) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Atrys Health's Liquidation Value for the quarter that ended in Dec. 2025 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	13.239	-	342.084	+	0.75 * 29.456	+	0.5 * 2.236
=	-305.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atrys Health Total Current Assets Related Terms

Atrys Health Total Current Assets Historical Data

* Premium members only.

The historical data trend for Atrys Health's Total Current Assets can be seen below:

Atrys Health Total Current Assets Chart

Atrys Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Current Assets

Get a 7-Day Free Trial

101.76

101.87

100.87

89.18

233.96

Atrys Health Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Total Current Assets	Get a 7-Day Free Trial															100.87	93.18	89.18	91.98	233.96

68GF Score

Atrys Health SA XMAD:ATRY

Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Atrys Health Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Atrys Health's Total Current Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	13.239	+	30.917	+	2.236	+	187.567
	=	234.0

Atrys Health's Total Current Assets for the quarter that ended in Dec. 2025 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	13.239	+	30.917	+	2.236	+	187.567
	=	234.0

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →

What does a Total Current Assets of €234.0 Mil mean?

Atrys Health (XMAD:ATRY) has a Total Current Assets of €234.0 Mil as of Dec. 2025. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Atrys Health and its competitors.

Is Atrys Health's Total Current Assets too high?

Atrys Health's current Total Current Assets is €234.0 Mil. Overall, Atrys Health has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Atrys Health's Total Current Assets compare to VRTX and REGN?

Atrys Health's Total Current Assets of €234.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Current Assets for a Biotechnology company?

A good Total Current Assets depends on the Biotechnology industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Current Assets mean?

A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Atrys Health and its competitors. Atrys Health's current Total Current Assets is €234.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Atrys Health stock overvalued right now?

Based on GuruFocus' analysis, Atrys Health (XMAD:ATRY) is currently considered Modestly Undervalued. The stock's GF Value™ is €3.11, compared to a current price of €2.58 — trading 17% below its estimated fair value. The current Total Current Assets is €234.0 Mil. Atrys Health's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Current Assets calculated?

Total Current Assets is calculated from a company's financial statements. For Atrys Health (XMAD:ATRY), the current Total Current Assets is €234.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Atrys Health (XMAD:ATRY) Overvalued in 2026?

Based on GuruFocus' analysis, Atrys Health stock appears to be undervalued. The current stock price of €2.58 is trading 17% below its estimated GF Value™ of €3.11. GuruFocus considers Atrys Health to be Modestly Undervalued.

Key valuation signals for XMAD:ATRY:

Total Current Assets: €234.0 Mil
GF Value™: €3.11 vs. price of €2.58 (17% below fair value)
GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the XMAD:ATRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Atrys Health Business Description

Industry Healthcare Biotechnology

Comparable Companies XMAD:ORY XMAD:VYT XMAD:BST VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA XKRX:068270 RPRX ROIV BNTX INCY INSM HKSE:02269

Other Exchanges A2T:Germany

Address Calle Provenca, 392 planta baja, Barcelona, ESP, 08025

Website https://www.atryshealth.com

Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.

68GF Score

Get the complete analysis for XMAD:ATRY

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.58

Price

€3.11

GF Value

View XMAD:ATRY Analysis

See Total Current Assets data for all stocks →